Skip to content

Novavax NVAX Price / sales

Price / sales at other companies

Moderna logo
ModernaMRNA
9.1×+5.6×
Roivant Sciences logo
Roivant SciencesROIV
2,400.1×+2,152×
Merck & Co. logo
Merck & Co.MRK
4.5×+1.0×
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
28.2×-3,609×
ALN
Alnylam PharmaceuticalsALNY
10.2×-4.6×
Gilead Sciences logo
Gilead SciencesGILD
5.8×+1.0×

Other financials

Income statement

See full
Revenue$139.5M-79.1%
Gross profit$108.8M-83.3%
Operating income-$15.4M-103%
Net income-$9.5M-102%
EPS (diluted)-$0.06-102%

Balance sheet

See full
Cash & equivalents$228.4M-13.3%
Total debt$295.1M+404%
Total equity-$144.8M-91.4%
Total assets$1.0B-19.3%

Cash flow

See full
Operating cash flow-$32.4M+82.5%
CapEx$1.3M-20.4%
Free cash flow-$33.7M+82.0%

Valuation

See full
Market cap$1.46B+28.6%
Enterprise value$1.53B+68.6%

Profitability

See full
Gross margin85%-2.5pp
Operating margin-13.1%-45.9pp
Net margin-14.7%-52.9pp
FCF margin-58.9%-61.4pp

Returns & leverage

See full
Return on equity-238.6%
Debt / equity1.5×
Current ratio2.5×+0.4×

Where this comes from

Calculated from Novavax’s reported figures.

Based on the most recent quarter.

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Novavax's price / sales?
Novavax (NVAX) reported price / sales of 2.2× in Q1 2026.
How has Novavax's price / sales changed year-over-year?
Novavax's price / sales increased by 170.7% year-over-year, from 0.8× to 2.2×.
What is the long-term trend for Novavax's price / sales?
Over 5 years (2020 to 2025), Novavax's price / sales has grown at a -44.0% compound annual growth rate (CAGR), from 17.7× to 1×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.